Our 7th Annual Open Meeting will take place at the Royal College of Physicians, London on March 10, 2020.
Attendees qualify for 8 CPD credits.
Welcome : Professor Sir Munir Pirmohamed
Precision Public Health : Professor Sir John Bell
The NHS Genomic Medicine Service : Professor Dame Sue Hill
Chromosomal instability and genome plasticity in cancer evolution, immune evasion and metastasis : Professor Charles Swanton
Session 2: Early Career Researchers
Polygenic Risk Scoring - An Overview of Theory, Practice and Usefulness for using Genetic Data in Risk Prediction : Dr Jack Euesden
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens : Dr Fiona Behan
Machine learning for healthcare : Anne Mottram
Patient experience of genomic medicine: Anne Lennox
Session 3: Nucleic acid based therapies
Somatic and germline genome editing - promises, perils and pipedreams : Professor Robin Lovell-Badge
Antisense oligonucleotide therapy for Huntington's disease : Professor Sarah Tabrizi
Gene therapy in haemophilia : Professor Edward Tuddenham
Session 4: Rare Diseases
Rare Disease Clinical Development - Locked Nucleic Acid therapy for Angelman Syndrome : Dr Michelle Krishnan
Pulmonary arterial hypertensions - molecular stratification of a rare disease : Professor Martin Wilkins
Evolving insights into AAV (adeno-associated virus)-based gene therapies for neuromuscular diseases: Professor Thomas Voit
Close of conference : Professor Sir Munir Pirmohamed
Once again we have some excellent speakers with Sir John Bell and Dame Sue Hill providing keynote addresses.
Charles Swanton will highlight how precision medicine in cancer is moving forward and this year there will be sessions on the latest advances in gene based therapies and rare diseases. Early career researchers will present their cutting edge work, and a patient will give an insight of their experience of genomic medicine.
The meeting attracts leading representatives from academia, healthcare and industry sectors, regulators, and patients, so is an ideal opportunity to forge multidisciplinary network partnerships.
Each year the meeting is a sell-out and all proceeds from the event go to funding our endeavours of promoting the use of personalised medicine in the clinic to provide patients with improved healthcare.